CFRPA
ANIP icon

Castle Financial & Retirement Planning Associates’s ANI Pharmaceuticals ANIP Stock Holding History

Castle Financial & Retirement Planning Associates’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$13K Buy
+327
New +$14.1K 0.04% 82

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Castle Financial & Retirement Planning Associates's ANIP Position: Q4 2021 in Review

Castle Financial & Retirement Planning Associates opened a new position in ANI Pharmaceuticals (ANIP) in Q4 2021: 327 shares worth $13K. The stake represents 0.04% of the portfolio and ranks #82 among its holdings.

132 funds tracked by Wall St. Rank hold ANIP as of Q4 2021.

  • Castle Financial & Retirement Planning Associates held 327 shares of ANI Pharmaceuticals worth $13K as of Q4 2021.
  • ANI Pharmaceuticals was a new Castle Financial & Retirement Planning Associates position in Q4 2021.
  • ANI Pharmaceuticals made up 0.04% of Castle Financial & Retirement Planning Associates's portfolio in Q4 2021, its #82 holding.
  • 132 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2021.

Based on Castle Financial & Retirement Planning Associates's 13F filing for Q4 2021, filed 14 Feb 2022.